Heparin-Induced Thrombocytopenia Score Card Study

Status Completed

Clinical Trial Summary

Main Research Question:

Can two new types of test, one called the 4T's score and the other called a rapid assay, help doctors correctly identify which patients are unlikely to have heparin-induced thrombocytopenia (HIT)?

HIT is a severe allergic reaction to the blood thinner heparin. This allergic reaction can lead to heart attacks, strokes, limb amputations, and death. Because heparin is one of the most commonly used drugs in the hospital setting, it is very important that the investigators are able to correctly identify who can safely continue to take heparin and who cannot.

It can be very difficult to diagnose HIT because it can look like many other medical conditions and the best laboratory tests for HIT are difficult to run and only available at specialized centres.

It would be very helpful if doctors had tests they could use that would tell them quickly and accurately which patients with symptoms that look like HIT really do have HIT (and require urgent treatment with another type of blood thinner) and which patients are very unlikely to have HIT (and could continue to take heparin safely). In this study, the investigators will compare the 4T's score (a scoring system that assigns "points" to the presence or absence of specific clinical features) and a rapid laboratory test with the old laboratory test to find out if one or both of these types of tests are useful for telling doctors which patients have HIT and which patients don't have HIT.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00489437
Study type	Interventional
Source	McMaster University
Contact
Status	Completed
Phase	Phase 1
Start date	December 2007
Completion date	February 2013

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00759083` - Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients	Phase 4
Completed	`NCT00412464` - Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis	Phase 1
Completed	`NCT00456326` - Heparin-Induced Thrombocytopenia Registry	N/A
Terminated	`NCT00673439` - Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)	Phase 2
Active, not recruiting	`NCT00198575` - A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients	N/A
Completed	`NCT00283322` - Heparin Antibodies in Intensive Care Unit Patients (HAICU)	N/A
Not yet recruiting	`NCT05586854` - Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia	N/A
Not yet recruiting	`NCT03269019` - Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia	N/A
Not yet recruiting	`NCT06066762` - Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.
Terminated	`NCT03809481` - Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban	Phase 3
Completed	`NCT05325346` - A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects	Phase 1
Recruiting	`NCT02717039` - Pharmacogenomics of Heparin-Induced Thrombocytopenia
Completed	`NCT02526485` - Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Completed	`NCT00748839` - Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical	N/A
Recruiting	`NCT05783895` - Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery
Not yet recruiting	`NCT04782843` - Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.
Completed	`NCT00198588` - Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia	Phase 3
Recruiting	`NCT04842760` - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Terminated	`NCT01598168` - Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia	Phase 3
Completed	`NCT01654848` - Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients	N/A